JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
KSU
2651
CALL
DELISTED
Kansas City Southern
KSU
| $4.23M | ﹤0.01% |
35,000
| – | – |
2019 Q1
1 quarter
|
|
|
KSU
2652
PUT
DELISTED
Kansas City Southern
KSU
| $4.23M | ﹤0.01% |
35,000
| – | – |
2019 Q1
1 quarter
|
|
|
SVM
2653
Silvercorp Metals
SVM
$2.32B
| $4.22M | ﹤0.01% |
1,681,313
+275,347
| +20% | +$632K |
2017 Q2
8 quarters
|
|
2654
Flowserve
FLS
$9.32B
| $4.22M | ﹤0.01% |
81,852
-54,697
| -40% | -$2.69M |
2013 Q2
24 quarters
|
|
|
CLDR
2655
DELISTED
Cloudera, Inc.
CLDR
| $4.2M | ﹤0.01% |
790,083
-3,469,549
| -81% | -$32M |
2017 Q2
8 quarters
|
|
2656
BJ's Restaurants
BJRI
$1.3B
| $4.2M | ﹤0.01% |
97,758
+90,135
| +1,182% | +$4.13M |
2016 Q1
13 quarters
|
|
2657
PUT
Boston Scientific
BSX
$61.1B
| $4.19M | ﹤0.01% |
100,000
+50,000
| +100% | +$1.92M |
2017 Q4
6 quarters
|
|
2658
CALL
KKR & Co
KKR
$81.4B
| $4.19M | ﹤0.01% |
168,100
-8,300
| -5% | -$199K |
2018 Q4
2 quarters
|
|
2659
VEON
VEON
$5.26B
| $4.17M | ﹤0.01% |
58,798
+31,879
| +118% | +$1.91M |
2013 Q2
24 quarters
|
|
2660
Enova International
ENVA
$4.55B
| $4.17M | ﹤0.01% |
185,221
+58,174
| +46% | +$1.39M |
2015 Q4
14 quarters
|
|
2661
iShares Global Energy ETF
IXC
$3.07B
| $4.17M | ﹤0.01% |
129,319
-41,619
| -24% | -$1.37M |
2013 Q2
24 quarters
|
|
2662
ATI
ATI
$26.5B
| $4.15M | ﹤0.01% |
167,132
+5,479
| +3% | +$134K |
2016 Q4
10 quarters
|
|
|
HPR
2663
DELISTED
HighPoint Resources Corporation
HPR
| $4.14M | ﹤0.01% |
44,728
+20,959
| +88% | +$2.34M |
2018 Q1
5 quarters
|
|
2664
The Greenbrier Companies
GBX
$1.24B
| $4.11M | ﹤0.01% |
140,479
+26,788
| +24% | +$850K |
2014 Q3
19 quarters
|
|
|
QTS
2665
DELISTED
QTS REALTY TRUST, INC.
QTS
| $4.11M | ﹤0.01% |
89,793
+26,987
| +43% | +$1.23M |
2015 Q1
17 quarters
|
|
2666
PUT
Humana
HUM
$48.5B
| $4.1M | ﹤0.01% |
15,500
-95,000
| -86% | -$24.1M |
2017 Q3
7 quarters
|
|
|
MDCO
2667
CALL
DELISTED
Medicines Co
MDCO
| $4.09M | ﹤0.01% |
115,000
+90,000
| +360% | +$2.94M |
2016 Q1
13 quarters
|
|
|
DHF
2668
BNY Mellon High Yield Strategies Fund
DHF
$161M
| $4.09M | ﹤0.01% |
1,339,737
-774,460
| -37% | -$2.37M |
2015 Q3
15 quarters
|
|
2669
Invesco KBW Bank ETF
KBWB
$6.23B
| $4.08M | ﹤0.01% |
82,546
-18,533
| -18% | -$931K |
2017 Q2
8 quarters
|
|
2670
Carpenter Technology
CRS
$19.6B
| $4.08M | ﹤0.01% |
84,580
+31,256
| +59% | +$1.47M |
2013 Q2
24 quarters
|
|
2671
Four Corners Property Trust
FCPT
$2.34B
| $4.08M | ﹤0.01% |
150,363
+57,348
| +62% | +$1.64M |
2015 Q4
14 quarters
|
|
|
B
2672
CALL
Barrick Mining
B
$67B
| $4.08M | ﹤0.01% |
260,000
+220,000
| +550% | +$2.92M |
2014 Q4
18 quarters
|
|
2673
iShares US Medical Devices ETF
IHI
$3.49B
| $4.08M | ﹤0.01% |
102,510
+23,706
| +30% | +$897K |
2015 Q4
14 quarters
|
|
|
NSL
2674
DELISTED
NUVEEN SENIOR INCM FD
NSL
| $4.08M | ﹤0.01% |
695,717
-299,548
| -30% | -$1.76M |
2013 Q2
24 quarters
|
|
2675
National Beverage
FIZZ
$2.81B
| $4.06M | ﹤0.01% |
184,416
+68,380
| +59% | +$1.76M |
2016 Q4
10 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.